Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Lumizyme (Alglucosidase Alfa) Covered by Blue Cross Blue Shield in New York: Appeals Guide and Templates

Answer Box: Getting Lumizyme Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield requires prior authorization for Lumizyme (alglucosidase alfa) in New York. To get approved: (1) Ensure your prescriber is a metabolic specialist, neurologist, or geneticist, (2) Submit GAA enzyme test results and genetic confirmation

Get Pombiliti Covered by Blue Cross Blue Shield in New York: ICD-10, J-Code, and Billing Guide

Answer Box: Blue Cross Blue Shield plans in New York require prior authorization for Pombiliti (cipaglucosidase alfa) using specific coding requirements. Use ICD-10 code E74.02 for Pompe disease, HCPCS J1203 for billing (per 5 mg), and submit via your BCBS provider portal with complete diagnostic documentation. If denied, you

How to Get Zanzalintinib (XL092) Covered by Blue Cross Blue Shield in New York: Appeals Guide and State Protections

Answer Box: Getting Zanzalintinib (XL092) Covered in New York Zanzalintinib (XL092) is investigational and typically not covered by Blue Cross Blue Shield outside clinical trials. However, New York residents have strong appeal rights through the Department of Financial Services external review process. First step: Request a formulary exception from BCBS

Get Strimvelis Gene Therapy Covered by Blue Cross Blue Shield in Georgia: Complete Guide with Forms, Appeals, and Travel Authorization

Quick Answer: Your Path to Coverage Getting Strimvelis gene therapy covered by Blue Cross Blue Shield in Georgia requires a medical exception since this treatment is only available at SR-TIGET in Milan, Italy and isn't FDA-approved in the U.S. Start by gathering genetic testing confirming ADA-SCID diagnosis,

How to Get Cerezyme (Imiglucerase) Covered by Blue Cross Blue Shield of Michigan: 2024 PA Requirements, Appeals Process & Forms

Answer Box: Getting Cerezyme Covered by Blue Cross Blue Shield of Michigan Good news for Michigan patients: Blue Cross Blue Shield of Michigan (BCBSM) covers Cerezyme as its preferred enzyme replacement therapy for Type 1 Gaucher disease. As of January 1, 2024, no prior authorization is required for Medicare Advantage

How to Get Tegsedi (Inotersen) Covered by Blue Cross Blue Shield of California: Complete Guide with Forms and Appeal Steps

Quick Answer: Getting Tegsedi Approved in California Blue Cross Blue Shield of California requires prior authorization for Tegsedi (inotersen), REMS program enrollment, and ongoing lab monitoring. Most patients need to show first-line therapy failure before approval. If denied, California's Independent Medical Review (IMR) process offers strong appeal rights

How to Get Tepezza (Teprotumumab) Covered by Blue Cross Blue Shield in North Carolina: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Tepezza Covered by BCBS in North Carolina Tepezza (teprotumumab) requires prior authorization from Blue Cross Blue Shield of North Carolina for thyroid eye disease coverage. Your fastest path to approval: 1) Gather comprehensive TED documentation including Clinical Activity Score (CAS ≥3), proptosis measurements, and prior therapy failures;

Get Brensocatib (BRINSUPRI) Covered by Blue Cross Blue Shield in California: Complete Prior Authorization & Appeal Guide

Answer Box: Your Path to Brensocatib Coverage in California Getting Brensocatib (BRINSUPRI) covered by Blue Cross Blue Shield in California requires prior authorization with strict clinical criteria. You'll need documented non-cystic fibrosis bronchiectasis, ≥2 exacerbations in the past year, and evidence of failed/intolerable macrolide therapy plus airway

Myths vs. Facts: Getting Evrysdi (Risdiplam) Covered by Blue Cross Blue Shield in North Carolina

Answer Box: Evrysdi Coverage in North Carolina Myth: If your doctor prescribes Evrysdi, Blue Cross Blue Shield automatically covers it. Fact: Prior authorization is required with specific documentation including genetic testing, baseline motor assessment, and medical necessity justification. To get started: (1) Confirm your Blue Cross NC plan's

Myths vs. Facts: Getting Ultomiris (ravulizumab) Covered by Blue Cross Blue Shield in Ohio - Appeals Process and Requirements

Answer Box: Getting Ultomiris Covered by BCBS in Ohio Fastest Path to Approval: Blue Cross Blue Shield in Ohio requires prior authorization for Ultomiris (ravulizumab) with new step therapy requirements effective July 2024—patients must try Empaveli (pegcetacoplan) first unless contraindicated. Submit PA requests through NovoLogix online tool with complete